| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Briacell Therapeutics Corp. (BCTX) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. BCTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | Lustig Marc | Director, 10% Owner | Buy | 902,935 | $2.22 | $2,000,001.03 | +55.1% | |
| Dec 28, 2022 | Bondarenko Jamieson | Chairman | Buy | 28,000 | $4.58 | $128,240.00 | +19.7% | |
| Dec 20, 2022 | Bondarenko Jamieson | Director | Buy | 22,000 | $5.35 | $117,700.00 | +18.4% |